Overview

Update
Total Equity Funding
$101M in 3 Rounds from 10 Investors
Most Recent Funding
$16M Series B on February 19, 2016
Headquarters:
San Diego, CA
Description:
Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
Founders:
, ,
Categories:
Health Care, Biotechnology, Medical
Website:
http://effector.com

Company Details

Update

eFFECTOR Therapeutics is an early stage company focused on the discovery and development of new small molecule cancer therapeutics. eFFECTOR is developing translation regulators to selectively block disregulated translation impacting tumor growth and survival. The company has selected control of mRNA translation as a key point of theerapeutic intervention, providing potency and selectivity while inhibiting growth of cancer cells. eFFECTOR's novel approach provides a real opportunity to bring innovative new medicines to patients in need.

Funding Rounds (3) - $101M

Update
DateAmount / RoundValuationLead InvestorInvestors
Feb, 2016$16M / Series B0
Dec, 2015$40M / Series B10
May, 2013$45M / Series A7

Current Team (3)

Update

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • Office

    11180 Roselle Street

    San Diego, CA 92121

    USA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos